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Ocular and Systemic Manifestations 
of Cerebrotendinous Xanthomatosis
J. R. M. CRUYSBERG, M.D., R. A. WEVERS, Ph,Dv 
B. G. M. van ENGELEN, M.D., A. PINCKERS, M.D., 
Æ van SPREEKEN, M ,DV AND I  I  M  TOLBOOM, M D ,
•  PURPOSE: Cerebrotendinous xanthomatosis is a 
storage disease that usually leads to severe mental 
and neurologic deterioration before the diagnosis 
and start of treatment are established. We identi­
fied major ocular and systemic characteristics that 
may enable a diagnosis to be made earlier.
•  METHODS: Ten patients (group 1) of the U ni' 
versity Hospital Nijmegen, with a diagnosis of 
cerebrotendinous xanthomatosis, were re-exam- 
ined for detailed ocular and major clinical mani­
festations. Meanwhile, we looked for similar but 
undiagnosed cases in patients (group 2) who 
visited the Institute of Ophthalmology during a 
12-month period.
•  RESULTS: A diagnosis of cerebrotendinous xan­
thomatosis had been made in the patients of group 
1 at an average age of 40 years (range, 33 to 48 
years). Subsequently, six new cases (group 2) were 
diagnosed in patients 7 to 37 years old (average 
age, 18 years). Bilateral cataract was the major 
ocular manifestation in all 16 patients. Small 
irregular corticonuclear opacities, anterior polar 
cataracts, and dense posterior subcapsular cata­
racts were diagnosed at various ages (mean, 18 
years; range, 4 to 40 years). Four patients 
showed clinical signs of optic neuropathy, 
whereas retinal function was normal in all pa-
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tients* Other major clinical signs included a history 
of chronic diarrhea (since childhood), mental de­
terioration (mean age, 23 years), neurologic deteri­
oration (mean age, 31 years), and tendon xantho­
mas (mean age, 37 years)*
•  C O N C L U S IO N S : Appropriate biochemical inves­
tigations for cerebrotendinous xanthomatosis 
should be performed in patients with unexplained 
juvenile or early-onset adult cataracts, especially if 
these cataracts are associated with chronic diar­
rhea silice infancy, mental retardation or deterio­
ration, neurologic dysfunction, or xanthomas.
IS u v
HRHi^ROTENDINOUS X A N T H O M A T O SIS  IS AN AU- 
tosomal recessive sterol storage disease with 
accumulation of cholestanol and cholesterol in 
most tissues* in particular, in xanthomas, bile, and 
brain.1 T h e  disease is caused hy a deficiency of 
hepatic mitochondrial 27-hydroxylase, 
volved in the biosynthesis of bile adds. T he  gene tor 
this enzyme is on chromosome 2, and mutations in 
the gene have been described/ T he  disease was first 
reported by van Bogaert, Scherer, and Epstein in 
1937/ T h e  patients they described had dementia,
ataxia, and cataracts and showed xanthomas in the 
tendons and nervous system. T he  disease is reported 
to be rare; however, cataract is a common finding/'2* 
Cerebrotendinous xanthomatosis results in progres­
sive neurologic and mental deterioration. It is now 
vitally important to establish the diagnosis at an  early 
age, because treatment with chenodooxychulic acid
in a favorable biochemical re-reshas
sponse /,14,lA2i In this study, we analyzed the ocular 
and systemic manifestations of cerebrotendinous xan­
thomatosis, with special emphasis on the contnbu-
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tion of the ophthalmologist in the early clinical 
diagnosis. Attention to the ocular manifestations may 
improve the recognition of this devastating metabolic 
disease, which is usually not diagnosed until many 
years after the initial manifestations.
PATIENTS AND METHODS
IN 1990, W E STARTED A  PROSPECTIVE O PH T H A L M O LO G IC  
examination of ten patients with cerebrotendinous 
xanthomatosis, which was diagnosed between 1982 
and 1989 at the University Hospital Nijmegen. Cere-
the Table and Figure 1. There were seven male and 
nine female patients, all of whom had bilateral 
cataract as an initial sign at a young age (mean, 18 
years; range, 4 to 40 years), followed by mental 
deterioration (mean age, 23 years; range, 4 to 40 
years) and neurologic deterioration (mean age, 31 
years; range, 15 to 43 years), Two patients were 
mentally retarded since childhood. Xanthomas were 
diagnosed only in adults (mean age, 37 years; range, 
32 to 43 years), whereas chronic diarrhea had oc­
curred in most patients since childhood.
The mean age at diagnosis of our first ten patients 
(group 1) was 40 years (range, 33 to 48 years). In two
brotendinous xanthomatosis was confirmed in these patients (Patients 1 and 5), the diagnosis of cerebro-
patients by gas chromatography of urinary bile alco- tendinous xanthomatosis was made at necropsy. The
hols and by determination of cholestanol in  blood.2“ mean age at diagnosis of our last six patients (group
While we were performing this study and looking 2) was 18 years (range, 7 to 37 years). The diagnosis
for similar patients in our daily practice, six additional was made much earlier in patients of group 2 than in
cases were diagnosed in 1991. In four of these cases, 
we recognized the clinical picture by routine ocular 
examination and medical history, after which the 
diagnosis was confirmed biochemically. The two 
other cases were found by urine examination of 
siblings. All patients underwent ophthalmologic ex­
group L The two youngest patients (Patients 11 and 
12) were hospitalized elsewhere, because of unex­
plained diarrhea, before cerebrotendinous xanthoma­
tosis was diagnosed as the cause of associated bilateral
cataract.
All 16 patients developed bilateral cataracts before
amination, including testing of best-corrected visual the age of 40 years, and these cataracts were diag 
acuity, refraction, external examination, anterior seg- | nosed before the age of 10 years in seven (44%) 
ment slit-lamp microscopy and photography, mea­
surement of intraocular pressure, ophthalmoscopy, 
echography, elaborate color vision testing, electroreti-
patients, and before the age of 20 years in ten (63%) 
patients. With slit-lamp examination, all lenses 
showed multiple small opacities, which were more
nography, electro-oculography, visual-evoked cortical pronounced in the anterior and posterior cortex than
potentials (with pattern reversal check sizes of 17, 10, 
and 7 minutes of arc), and  Goldmann visual field 
examination. A detailed medical history was ob­
tained, and previous ophthalmic data were collected 
from our own records and from records of other 
ophthalmologists. M ain systemic findings were ob­
tained in the Departments of Neurology or Pediatrics 
during clinical observation of the patients with cere­
brotendinous xanthomatosis.
RESULTS
CEREBROTENI )JNOUS X A N T H O M A T O SIS  WAS ESTAB- 
lished in 16 patients from six unrelated nonconsan- 
guineous Dutch families (Families A, B, C, D, F, and 
U) and one consanguineous German family (Family 
E). T he  major clinical symptoms are summarized in
in the nucleus (Fig. 2). Four patients had bilateral 
anterior polar cataract (Fig. 3), in addition to the 
cortical and nuclear opacities. At the time that vision 
had red need ma rked ly, the 
posterior subcapsular cataract (Fig. 4). The cataracts 
progressed to maturity. Ten of the 16 patients under­
went cataract surgery (first eye), at an average age of 
20 years (range, 7 to 52 years). Four patients (Patients 
5, 6, 8, and 12) underwent cataract surgery before age 
10 years. At least eight patients (Patients 1, 3, 4 -8 , 
and 12) were, or will be, aphakic at age 40 years. In 
contrast, none of the 14 parents of the 16 patients 
underwent cataract surgery.
Before cataract surgery, eight patients had specta­
cles for moderate myopia, and none had spectacles for 
hypermetropia. With surgical treatment of these cata­
racts, best-corrected visual acuity of at least 20/40 was 
attained bilaterally in all patients, except in an
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TABLE
CATARACT AND SYSTEMIC FEATURES OF CEREBROTENDINOUS XANTHOMATOSIS
PATIENT NO., 
PEDIGREE, 
GENDER
AGE AT 
DEATH
(YRS) M AJOR SIGNS OF TH E SYNDROME
AGE AT W HICH  
SYM PTO M S W ERE  
D O C UM EN TED  
(yrs)
AGE AT 
DIAGNOSIS
{YflB)
1, A-1, F 48 Bilateral cataract (corticonuclear and posterior polar) 17 48
Chronic diarrhea <30
Neurologic and mental dysfunction (pyramidal and 30
cerebellar signs and mental deterioration)
2, A-4, M — Bilateral cataract (anterior polar and anterior subcapsular) 22 37
Mental retardation 4
Neurologic dysfunction (pyramidal and cerebellar 37
signs and peripheral neuropathy)
3, A-5, M — Bilateral cataract (anterior polar and anterior subcapsular) 27 33
Neurologic dysfunction (pyramidal and cerebellar 33
• signs and peripheral neuropathy)
Xanthomas of the tibia 33
History of chronic diarrhea 33
4, B-2, F — Bilateral cataract 18 36
Neurologic dysfunction (cerebellar signs and 18
peripheral neuropathy)
Mental deterioration 33
5, C-2, M 42 Bilateral cataract g 42
Mental deterioration 15
Neurologic dysfunction (pyramidal and cerebellar signs) 30
Xanthomas of the Achilles tendon 32
6, C-3, M — Bilateral cataract 4 41
Chronic diarrhea since childhood
Mental deterioration 15
Neurologic dysfunction (pyramidal and cerebellar signs) 30
Xanthomas of the Achilles tendons and hands 41
7, C-8, F — Bilateral cataract 9 34
Chronic diarrhea since childhood
Neurologic and mental dysfunction (pyramidal and cerebellar signs, 15
peripheral neuropathy, and mental deterioration)
Xanthomas of the Achilles tendons 34
8, D-2, M — Chronic diarrhea since childhood 46
Bilateral cataract 8
Neurologic and mental dysfunction (pyramidal and cerebellar signs 35
and mental deterioration)
Xanthomas of the Achilles tendons 35
■9, D-4, F 54 Chronic diarrhea since childhood 43
Bilateral cataract (anterior cortical, posterior cortical, 40
and posterior subcapsular)
Neurologic dysfunction (pyramidal and cerebellar signs 40
and mental deterioration)
Xanthomas of the Achilles tendons, right hand, elbow 43
10, D-7, F — Chronic diarrhea since childhood 40
Bilateral cataract (mild cortical opacities) 40
Achilles tendon xanthoma 40
Neurologic dysfunction (pyramidal signs) 43
11, E-1, M »1 Chronic diarrhea since Infancy 2 13
Bilateral cataract (anterior cortical, posterior cortical, 9
and posterior subcapsular)
Continued on next page
TABLE (Continued)
CATARACT AND SYSTEMIC FEATURES OF CEREBROTENDINOUS XANTHOMATOSIS
PATIENT NO., 
PEDIGREE, 
GENDER
AGE AT 
DEATH
|YRS) MAJOR SIGNS OF THE SYNDROME
AGE AT WHICH 
SYMPTOMS WERE 
DOCUMENTED
(YRS)
AGE AT 
DIAGNOSIS
(YRS)
12, E-3, F Chronic diarrhea since Infancy 2 7
Bilateral cataract (anterior cortical, posterior cortical, 4
and posterior subcapsular)
13, F-9, F — Chronic diarrhea since infancy 37
Bilateral cataract (anterior polar and posterior subcapsular) 33
Neurologic and mental dysfunction (pyramidal and 33
cerebellar signs and mental deterioration)
14, G-3, M — Chronic diarrhea since infancy 2 12
Psychomotor retardation 7
Bilateral cataract (anterior polar and corticonuclear) 9
15, G-1, F — Cataract (mild cortical opacities) 20 20
16, G-2, F — Cataract (mild cortical opacities) 17 17
amblyopic eye (Patient 4) and one eye in a patient 
with unilateral bullous keratopathy (Patient 6). Pos­
terior chamber intraocular lens implantation was 
uneventful M ean aphakic refraction was 12,0 diop­
ters (range, 6.0 to 15.5 diopters) in the five patients 
who had received no intraocular lenses.
Nystagmus and strabismus were relatively rare, Two 
patients (Patients 5 and 7) had gaze-induced nystag­
mus, Two patients (Patients 4 and 8) showed exotro-
% Prevalent:« (% ) or m njor mnnlfi!N(atlotis n l vhHquSI (Yru)
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Fig. 1 (Cr ays berg and associates). Prevalence of major 
manifestations of cerebrotendinous xanthomatosis at 
various ages. Note that in the first decade the prevalence 
of cataract and diarrhea is higher than mental or neuro­
logic manifestations (Neuro/mental), whereas the classic 
xanthomas were found only in adults older than 30 years 
of age.
pia of the left eye. Horizontal corneal diameters were 
ail within normal limits. Corneas were clear, except 
for a postherpetic corneal leukoma in the right 
cornea of Patient 2 and a bullous keratopathy after 
cataract surgery with anterior chamber lens implanta­
tion in Patient 6. Bilateral arcus lipoides corneae was 
present in Patient 8. Bilateral eyelid xanthelasma was 
present in two patients (Patients 8 and 9), 54 and 51 
years old, respectively, One 46-year-old sibling (Fami­
ly C) showed bilateral eyelid xanthelasma; however, 
this patient had no clinical or biochemical signs of 
cerebrotendinous xanthomatosis. Pupillary appear­
ance and reactivity to light were generally normal.
,iic examination of pane
showed no unusual findings, except for some degree of 
paleness of the optic disks in Patient I at age 44 years, 
Patient 8 at age 54 yeans, and Patient 1.3 at age 36 
years. Intraocular pressures were within normal limits, 
except for the left eye of Patient 8,
By echography, axial length measurements in adult 
patients disclosed no unusual values (average, 23.0
mm; range, 21.5 to 27.5 mm). Electroretinography,
electro-oculography, or both, were performed in 
seven patients and were found to he within normal 
limits in all examined eyes. Visual-evoked cortical 
:ials with pattern reversal stimulation were ex­
in 13 patients and showed bilateral abnormal 
latencies (Patients 5, 8, and 11-13), were not record­
able (Patient 6), or had unilateral abnormalities
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Fig* 2 (Cruysberg and associates). Patient 11. Slit-lamp 
photograph of the left lens of a child with chronic 
diarrhea and bilateral cortical cataract, showing multiple 
line-shaped cortical opacities.
because of low visual acuity (Patients 2 and 9). 
Normal pattern reversal visual-evoked cortical poten­
tials were found in five patients (Patients 3, 7» and 
14-16). Visual-evoked cortical potentials with flash 
stimulation were found to be present in all examined 
patients; however, the response was weak in the right 
eye of Patient 11. Reliable color vision testing and 
visual field examination were possible in only a 
limited number of patients because of mental deterio­
ration. Color vision testing disclosed an acquired type 
II red-green defect of Verriest in two patients (Patients 
3 and 13), In Patient 9, color vision was severely 
disturbed without any typical defect. Goldmann visu­
al field examination was performed in seven patients 
and was found to be abnormal only in the patient
with glaucomatous field loss (Patient 8), At least four 
patients (Patients 1, 3, 8, and 13) had optic neuropa­
thy, because of pale optic disks, abnormal latencies of 
visual-evoked potentials, acquired type II color vision 
defects, or a combination of symptoms.
Aspirated lens material was examined in one 
patient (Patient 14) and disclosed a cholestanol/ 
cholesterol ratio of 1.71, which was more than five 
times higher than  the ratio of 0.33 that was found in
cataractous lens material of a control patient.
DISCUSSION
CE R E BROT EN DIN O U S  X A N T H O M A T O SIS  IS CLASSICALLY
characterized by the following four major features: (1) 
bilateral cataracts, (2) progressive dysfunction of the 
central nervous system with mainly pyramidal tract 
signs and cerebellar ataxia, (3) mental deterioration, 
and (4) tuberous and Achilles tendon xanthomas. 
Findings in other studies included peripheral neurop­
athies, foot deformity, cardiovascular disease or ather­
osclerosis, history of cholecystectomy because of gall­
stones, and endocrine abnormalities.'^,t4,15,17,21 In many 
patients, symptoms begin at about the age of 10 years, 
but the diagnosis of cerebrotendinous xanthomatosis 
is made about 20 to 30 years later,21 sometimes even 
more than  40 years later.17 We established a diagnosis 
of cerebrotendinous xanthomatosis in young patients 
(Families E and G), because we recognized the 
association of juvenile cataract and chronic diarrhea 
as a major clinical feature of cerebrotendinous xan­
thomatosis in childhood.21
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Fig. 3 (Cruysberg and associates). Patient 2. Bilateral anterior polar cataract. Anterior view of left eye (left) after 
dilation of the pupil. Slit-lamp photograph of left eye (right), showing dense anterior polar cataract and diffuse 
corticonuclear lens opacity.
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Fig. 4 (Cruysberg and associates). Patient 12. Slit-1 amp 
photograph with retroillumination of the right lens of a 
child with chronic diarrhea, showing severe optical 
disturbance from posterior subcapsular cataract.
The clinical abnormalities are caused by accumula­
tion of eholestanol, the Sa-dihydro derivate of choles­
terol, in serum and tissues,5,6 including the cataract- 
ous lens.19 T he  formation of eholestanol results from a 
block in the metabolic pathway of bile acid synthesis/1 
which is accompanied by the formation of bile 
alcohols that are normally not detectable in urine.
We found that cataract was a symptom at onset in 
nearly all patients in this series but in only 35% of the 
cases described elsewhere,21 We established that the 
development of this cataract was present in nearly all 
patients before age 40 years. The cataracts are not 
congenital but may be diagnosed by age 10 years in 
nearly half of the patients. O ther researchers men­
tioned the development of cataract in the second
decade,^’1 U0,2L the decade,M,10‘l2,21 and the
fourth decade.11 Cataracts may be present without 
complaints of diminished vision,H
cataract extraction, visual acuity usually decreases to
less than  20/200 before age 40 years.9,13,18 A t the age of 
50 years, nearly all patients will be aphakic in at least
4 ! 5 Mone eycv^^1
The type of cataract is mentioned in only half of 
the cases described before 1975, and they were all 
zonular.3,8 Later, anterior and posterior cortical cata­
racts,9,10,13 anterior and posterior subcapsular cata­
racts/1'11,18 coronary cataract,18 and, as in some of our 
patients, anterior and posterior polar cataracts,12 were 
described, A n  ultrastructural study showed, especially 
in the anterior polar region of the lens, numerous 
vacuoles that were partially disrupted and filled with
dispersed granular content, whereas cells in the 
equatorial region appeared normal.11 The opacities in 
the anterior and posterior cortex have been described 
like a fine cerulean cataract, sometimes combined to 
form small clouds, or rods, with spoke formation in 
the lenses/0 blue-white dots,13 and snowflake-pattern 
cataracts.13 The subcapsular opacities appeared as 
irregular white dots, which sometimes mimicked 
whorls.11 The finding that four of our 16 patients 
initially had anterior polar cataract is remarkable, 
because this cataract type is considered to be less 
likely to progress24 and, therefore, engenders no suspi­
cion of metabolic disease.
Surgical extraction of these cataracts, with or 
without implantation of intraocular lenses, is associ­
ated with a good prognosis for visual recovery.'Ml,n,1H,2° 
The good visual prognosis and the rarity of strabismus 
and nystagmus in these patients demonstrate that the 
development of vision is not disturbed in early 
childhood. Furthermore, the visual recovery proves 
that dysfunction of the optic nerve, if present, is 
relatively mild.
In reported cases,11'13 preoperative refraction is for 
myopia, whereas refraction for aphakia is usually 
within normal limits.11
The optic disk may be pale but not atrophic,M In 
patients with cerebrotendinous xanthomatosis, pat­
tern reversal visual-evoked potentials may be within 
normal limits, absent because of cataract, or delayed 
because of optic neuropathy. Visual-evoked potentials 
showed slow nerve conduction velocities in live of 16 
patients in the present study and in two of seven cases 
in a recent study,21 If optic nerve dysfunction is 
established with visual-evoked potentials and color 
vision tests, then multiple sclerosis may be misdiag­
nosed in patients with progressive pyramidal tract 
signs and cerebellar ataxia. Acquired nystagmus, the
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result of cerebellar dysfunction in cerebrotendinous 
xanthomatosis,4,10 may further contribute to the mis- 
diagnosis of multiple sclerosis.
Xanthelasma is a planar xanthoma that may affect 
both eyelids in cerebrotendinous x a n th o m a to s iso r  
may be absent.4,11,12 Palpebral xanthelasma and corne­
al lipoid arcus are well known in patients with 
hypercholesterolemia25; however, plasma cholesterol 
levels are within normal limits in patients with 
cerebrotendinous xanthomatosis.4,5,1 * Other ocular 
signs are rare and may include unilateral proptosis 
caused by xanthoma deposition in the extraocular 
muscles18 or bilateral exophthalmos in the absence of 
thyroid dysfunction.21
Diagnosis of cerebrotendinous xanthomatosis may 
be difficult because results of routine examinations of 
blood, urine, and cerebrospinal fluid are normal.21 
T h e  value of urinary capillary gas chromatography of 
bile alcohols as a specific test to establish the diagno­
sis of cerebrotendinous xanthomatosis and to monitor 
the biochemical effectivity of the different treatment 
regimens has been emphasized.17,22 Appropriate bio­
chemical investigations for cerebrotendinous xantho­
matosis should be performed in patients with unex­
plained bilateral juvenile cataracts, especially if these 
cataracts are associated with any of the following 
signs: chronic diarrhea since infancy, mental retarda­
tion or deterioration, neurologic dysfunction, or xan­
thomas at any place. Cerebrotendinous xanthomato­
sis should be excluded if patients who are suspected to 
have multiple sclerosis develop cataract at a young 
age. Essentially, cerebrotendinous xanthomatosis 
should be included in the differential diagnosis of 
central nervous system disorders associated with cata­
ract.
From the present study, we concluded that the 
ophthalmologist can play an important role in the 
early diagnosis of this autosomal recessive disease. 
Because we have observed that treatment with che- 
nodeoxycholic acid has resulted in a favorable bio­
chemical response in children,21 we hope that early 
diagnosis and treatment prevent the devastating cen­
tral nervous system complications at a later age.
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